Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRent ExpenseResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Marketaxess Holdings (MKTX) Other Operating Expenses (2016 - 2026)

Marketaxess Holdings' Other Operating Expenses history spans 16 years, with the latest figure at $99.4 million for Q4 2025.

  • On a quarterly basis, Other Operating Expenses rose 7.21% to $99.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $384.5 million, a 4.87% increase, with the full-year FY2025 number at $384.5 million, up 4.87% from a year prior.
  • Other Operating Expenses hit $99.4 million in Q4 2025 for Marketaxess Holdings, up from $93.3 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for MKTX hit a ceiling of $99.4 million in Q4 2025 and a floor of $70.8 million in Q3 2021.
  • Historically, Other Operating Expenses has averaged $84.3 million across 5 years, with a median of $82.4 million in 2023.
  • Biggest five-year swings in Other Operating Expenses: grew 21.13% in 2023 and later grew 0.22% in 2025.
  • Tracing MKTX's Other Operating Expenses over 5 years: stood at $73.2 million in 2021, then grew by 3.47% to $75.7 million in 2022, then grew by 21.13% to $91.7 million in 2023, then increased by 1.02% to $92.7 million in 2024, then grew by 7.21% to $99.4 million in 2025.
  • Business Quant data shows Other Operating Expenses for MKTX at $99.4 million in Q4 2025, $93.3 million in Q3 2025, and $99.0 million in Q2 2025.